Skip to main content
SpringerLink
Log in

REVIEW: p53 and CD44 as clinical markers of tumour progression in colorectal carcinogenesis

  • Published:
The Histochemical Journal Aims and scope Submit manuscript

Abstract

Recent advances in molecular genetics have importantly improved our understanding of the development of colorectal cancer. The present review gives an overview of the clinical value of the tumour-suppress or gene, p53, and the CD44 cell adhesion molecule in colorectal cancer and the pitfalls encountered in the immunohistochemical detection of these proteins. Immunohistochemistry potentially forms a procedure applicable for routine diagnosis and prognostication. Therefore, p53 expression and the independent prognostic importance of CD44v6 expression is given particular emphasis, and other molecular events underlying colorectal carcinogenesis are only mentioned briefly

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Academic Medical Centre, University of Amsterdam, Department of Pathology, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands

    J. W. R. Mulder, V. J. M. Wielenga, S. T. Pals & G. J. A. Offerhaus

Authors
  1. J. W. R. Mulder
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. J. M. Wielenga
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. T. Pals
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. J. A. Offerhaus
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mulder, J.W.R., Wielenga, V.J.M., Pals, S.T. et al. REVIEW: p53 and CD44 as clinical markers of tumour progression in colorectal carcinogenesis. J Mol Hist 29, 439–452 (1997). https://doi.org/10.1023/A:1026403404652

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026403404652

Keywords

Search

Navigation